Data gathered: April 9
AI Stock Analysis - ARS Pharmaceuticals (SPRY)
Analysis generated March 14, 2025. Powered by Chat GPT.
ARS Pharmaceuticals is a biopharmaceutical company focused on developing innovative and life-saving therapies. The company's primary focus lies on targeted treatments designed to significantly improve patient outcomes. The company has recently garnered attention due to its promising pipeline of products and steady growth in the pharmaceutical sector. However, some internal and external factors indicate potential concerns that warrant a thorough analysis.
Stock Alerts - ARS Pharmaceuticals (SPRY)
 |
ARS Pharmaceuticals | April 9 Price is up by 5.1% in the last 24h. |
|
ARS Pharmaceuticals | April 9 Insider Alert: Shawver Laura is selling shares |
|
ARS Pharmaceuticals | April 8 Price is down by -5.2% in the last 24h. |
|
ARS Pharmaceuticals | April 7 Price is down by -5.2% in the last 24h. |
Alternative Data for ARS Pharmaceuticals
| Alternative Data | Value | 3m Change | Trend | Benchmark |
|---|---|---|---|---|
| Job Posts | 7 | Sign up | Sign up | Sign up |
| Sentiment | 100 | Sign up | Sign up | Sign up |
| Webpage traffic | 16,000 | Sign up | Sign up | Sign up |
| Employee Rating | 92 | Sign up | Sign up | Sign up |
| Google Trends | 27 | Sign up | Sign up | Sign up |
| 4chan Mentions | N/A | Sign up | Sign up | Sign up |
| Reddit Mentions | N/A | Sign up | Sign up | Sign up |
| Stocktwits Mentions | 5 | Sign up | Sign up | Sign up |
| Stocktwits Subscribers | 2,070 | Sign up | Sign up | Sign up |
| Twitter Followers | 505 | Sign up | Sign up | Sign up |
| Twitter Mentions | 25 | Sign up | Sign up | Sign up |
| News Mentions | N/A | Sign up | Sign up | Sign up |
| Customer reviews | N/A | Sign up | Sign up | Sign up |
| Business Outlook | 66 | Sign up | Sign up | Sign up |
| Linkedin Employees | 148 | Sign up | Sign up | Sign up |
About ARS Pharmaceuticals
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions.
| Price | $13.34 |
| Target Price | Sign up |
| Volume | 3,310,000 |
| Market Cap | $1.26B |
| Year Range | $9.32 - $17.49 |
| Dividend Yield | 0% |
| PE Ratio | 160 |
| Analyst Rating | 100% buy |
| Industry | Biotechnology |
In the news
 |
ARS Pharmaceuticals (SPRY): Among Unstoppable Stocks That Could Double Your MoneyApril 5 - Yahoo |
 |
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Given Average Rating of “Buy” by BrokeragesApril 1 - ETF Daily News |
|
FY2025 EPS Estimates for SPRY Lowered by Cantor FitzgeraldMarch 27 - ETF Daily News |
|
Intech Investment Management LLC Has $322,000 Position in ARS Pharmaceuticals, Inc. (NASDAQ:SPRY)March 26 - ETF Daily News |
|
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Analysts Are Reducing Their Forecasts For This YearMarch 25 - Yahoo |
|
Equities Analysts Issue Forecasts for SPRY FY2028 EarningsMarch 24 - ETF Daily News |
Financial performance View All
| Revenue | Cost of Revenue | Gross Profit | Net Income | ebitda | EPS | |
|---|---|---|---|---|---|---|
| Q3 '24 | 2.1M | 19M | -17M | -19M | -22M | -0.200 |
| Q2 '24 | 500,000 | 110,000 | 390,000 | -13M | -15M | -0.130 |
| Q1 '24 | 0 | 93,000 | -93,000 | -10M | -13M | -0.110 |
| Q4 '23 | 0 | -40M | 40M | -7.2M | -10M | -0.070 |
| Q3 '23 | 0 | 15M | -15M | -15M | -18M | -0.160 |
Insider Transactions View All
| Shawver Laura filed to sell 210,346 shares at $12.3. April 8 '25 |
| Karas Eric filed to sell 7,696 shares at $14. March 21 '25 |
| Shawver Laura filed to sell 210,346 shares at $11.2. March 7 '25 |
| Shawver Laura filed to sell 210,346 shares at $11. March 7 '25 |
| Shawver Laura filed to sell 210,346 shares at $12.3. February 4 '25 |
Similar companies
Read more about ARS Pharmaceuticals (SPRY) and their ai stock analysis, price prediction, earnings, congress trading, insider transactions, technical analysis, job posts, sentiment, webpage traffic, employee rating, google trends, 4chan mentions, reddit mentions, stocktwits mentions, stocktwits subscribers, twitter followers, twitter mentions, news mentions, customer reviews, business outlook & linkedin employees.
What is the Market Cap of ARS Pharmaceuticals?
The Market Cap of ARS Pharmaceuticals is $1.26B.
What is ARS Pharmaceuticals' PE Ratio?
As of today, ARS Pharmaceuticals' PE (Price to Earnings) ratio is 160.
What is the current stock price of ARS Pharmaceuticals?
Currently, the price of one share of ARS Pharmaceuticals stock is $13.34.
How can I analyze the SPRY stock price chart for investment decisions?
The SPRY stock price chart above provides a comprehensive visual representation of ARS Pharmaceuticals' stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling ARS Pharmaceuticals shares. Our platform offers an up-to-date SPRY stock price chart, along with technical data analysis and alternative data insights.
Does SPRY offer dividends to its shareholders?
As of our latest update, ARS Pharmaceuticals (SPRY) does not offer dividends to its shareholders. Investors interested in ARS Pharmaceuticals should consider the potential for capital appreciation as the primary return on investment, rather than expecting dividend payouts.
What are some of the similar stocks of ARS Pharmaceuticals?
Some of the similar stocks of ARS Pharmaceuticals are Amgen, Gilead Sciences, Catalyst Pharmaceuticals, Inovio Pharmaceuticals, and Anavex Life Sciences.
.